Pasireotide
| CAS No. | 396091-73-9 |
|---|---|
| MDL No. | MFCD08067735 |
| MF | C58H66N10O9 |
| MW | 1047.20 |
| InChI Key | VMZMNAABQBOLAK-DBILLSOUSA-N |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| - | - | On Request | On Request | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Product Information
Pasireotide is a six-membered homodetic cyclic peptide composed of L-phenylglycyl, D-tryptophyl, L-lysyl, O-benzyl-L-tyrosyl, L-phenylalanyl, and modified L-hydroxyproline residues. It is a somatostatin analogue with pharmacologic properties similar to the natural hormone somatostatin. Used as its diaspartate salt in the treatment of Cushing's disease, it functions as an antineoplastic agent, peptide hormone, and conjugate base of pasireotide(2+).
| CAS No. | 396091-73-9 |
|---|---|
| Product Name | Pasireotide |
Biological Targets
SSTR1·SSTR2·SSTR3·SSTR5
Associated Conditions
Hypoglycemia·meningioma·hepatocellular carcinoma·acromegaly·pituitary-dependent Cushing's disease·
* The information provided here is compiled from public sources and is for reference only.
